We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+26.41%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$8.88B
AUM Growth
+$2.09B
Cap. Flow
+$564M
Cap. Flow %
6.36%
Top 10 Hldgs %
40.05%
Holding
908
New
100
Increased
273
Reduced
455
Closed
75

Sector Composition

Rank Sector Weight
1 Energy 48.15%
2 Financials 11.06%
3 Technology 6.82%
4 Healthcare 5.49%
5 Industrials 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMLC icon
201
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.74B
$3.54M 0.04%
106,469
-2,890
-3% -$92.4K
WLDN icon
202
Willdan Group
WLDN
$1.1B
$3.43M 0.04%
82,283
+22,365
+37% +$777K
PYPL icon
203
PayPal
PYPL
$49.5B
$3.43M 0.04%
14,634
-7,105
-33% -$1.47M
EMB icon
204
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
$3.4M 0.04%
29,330
-160
-0.5% -$18.1K
IRWD icon
205
Ironwood Pharmaceuticals
IRWD
$611M
$3.29M 0.04%
289,162
+67,307
+30% +$737K
ETRN
206
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$3.29M 0.04%
409,755
+144,103
+54% +$1.15M
CL icon
207
Colgate-Palmolive
CL
$72.6B
$3.26M 0.04%
38,121
-2,526
-6% -$209K
AUPH icon
208
Aurinia Pharmaceuticals
AUPH
$1.97B
$3.15M 0.04%
227,815
+66,456
+41% +$967K
MA icon
209
Mastercard
MA
$477B
$3.14M 0.04%
8,784
+4,906
+127% +$1.63M
MDGL icon
210
Madrigal Pharmaceuticals
MDGL
$12.6B
$3.1M 0.03%
27,904
+8,222
+42% +$1M
REPL icon
211
Replimune Group
REPL
$814M
$3.1M 0.03%
81,295
+29,916
+58% +$1.25M
ADBE icon
212
Adobe
ADBE
$89.5B
$3.06M 0.03%
6,127
+749
+14% +$362K
RGNX icon
213
Regenxbio
RGNX
$623M
$3.06M 0.03%
+67,481
New +$2.36M
RCUS icon
214
Arcus Biosciences
RCUS
$3.57B
$3.05M 0.03%
+117,318
New +$2.84M
STEP icon
215
StepStone Group
STEP
$3.48B
$2.98M 0.03%
+75,000
New +$2.17M
DRNA
216
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$2.96M 0.03%
134,585
+39,628
+42% +$873K
UPS icon
217
United Parcel Service
UPS
$97.6B
$2.96M 0.03%
17,562
-116,288
-87% -$19.6M
MDLZ icon
218
Mondelez International
MDLZ
$77.7B
$2.92M 0.03%
49,850
+9,332
+23% +$533K
QURE icon
219
uniQure
QURE
$2.68B
$2.9M 0.03%
80,337
+23,657
+42% +$998K
LGND icon
220
Ligand Pharmaceuticals
LGND
$6.02B
$2.89M 0.03%
46,583
+13,721
+42% +$782K
GP
221
GreenPower Motor Co
GP
$10.5M
$2.89M 0.03%
+9,913
New +$1.6M
TGT icon
222
Target
TGT
$62.1B
$2.88M 0.03%
16,302
-629
-4% -$105K
ROL icon
223
Rollins
ROL
$18.6B
$2.84M 0.03%
72,604
-5,725
-7% -$222K
ZTS icon
224
Zoetis
ZTS
$31.6B
$2.83M 0.03%
17,128
-949
-5% -$154K
FAST icon
225
Fastenal
FAST
$54B
$2.79M 0.03%
114,284
-9,062
-7% -$213K

Similar funds

ALPS Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, ALPS Advisors held 908 positions worth $8.88B, up 31% from $6.79B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

ALPS Advisors deployed $564M of net new capital in Q4 2020, opening 100 new positions and adding to 273 existing holdings. Its largest new stake was Genuine Parts: 212,300 shares worth $21.3M.

By sector, the portfolio is most concentrated in Energy at 48% of assets, up from 46% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was WestRock Company, an estimated $23.3M trimmed.

  • ALPS Advisors's largest Q4 2020 buy was Genuine Parts: 212,300 shares worth $21.3M.
  • ALPS Advisors added most to Energy Transfer Partners in Q4 2020, an estimated $76.1M increase.
  • ALPS Advisors's biggest Q4 2020 reduction was WestRock Company, cutting an estimated $23.3M.
  • ALPS Advisors fully exited Duke Energy in Q4 2020, selling an estimated $20.8M.
  • ALPS Advisors's ten largest holdings make up 40% of its $8.88B portfolio in Q4 2020.
  • ALPS Advisors opened 100 new positions and closed 75 in Q4 2020.
  • ALPS Advisors's portfolio value rose 31% quarter-over-quarter to $8.88B.

Based on ALPS Advisors's 13F filing for Q4 2020, filed 3 Feb 2021.